Myocardial perfusion response to dipyridamole in hypertensive left ventricular hypertrophy: A human study using myocardial contrast echocardiography

Microvascular Research

Volumn 64, Issue 3, 2002, Pages 482-485

  Kozàkovà, Michaela ^a   Palombo, Carlo ^a,b   Paterni, Marco ^b   Buralli, Simona ^a   Ciardetti, Marco ^b   Magagna, Armando ^a   Rovai, Daniele ^b   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Arterial hypertension; Contrast echocardiography; Coronary microcirculation; Myocardial hypertrophy

Indexed keywords

DIPYRIDAMOLE; VASODILATOR AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DRUG MEGADOSE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; HYPERTENSION; MICROVASCULARIZATION; PRIORITY JOURNAL; ECHOCARDIOGRAPHY; HEART; HEART MUSCLE; MALE; METABOLISM; METHODOLOGY; PERFUSION; PHYSIOLOGY; TIME;

DIPYRIDAMOLE; ECHOCARDIOGRAPHY; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIUM; PERFUSION; TIME FACTORS; VASODILATOR AGENTS;

EID: 0036435180     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.2002.2445     Document Type: Article

References (6)

1. Frohlich, E. D. (1999). Risk mechanisms in hypertensive heart disease. Hypertension 34, 782-789.
2. Kaul, S., and Jayaweera, A. R. (1997). Coronary and myocardial blood volumes: Noninvasive tools to assess the coronary microcirculation? Circulation 96, 719-724.
3. Rovai, D., Lubrano, V., Vasalle, C., Paterni, M., Marini, C., Kozàkovà, M., Castellari, M., Taddei, L., Trivella, M. G., Distante, A., DeMaria, A. N., and L'Abbate, A. (1998). Detection of perfusion defects during coronary occlusion and myocardial reperfusion after thrombolysis by intravenous administration of the echo-enhancing agent BR1. J. Am. Soc. Echocardiogr. 11, 169-180.
4. Skyba, D. M., Camarano, G., Goodman, N. C., Price, R. J., Skalak, T. C., and Kaul, S. (1996). Hemodynamic characteristics, myocardial kinetics, and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from contrast injection. J. Am. Coll. Cardiol. 28, 1292-1300.
5. Tomanek, R. J., Palmer, P. J., Peiffer, G. L., Schreiber, K. L., Eastham, C. L., and Marcus, M. L. (1986). Morphometry of canine coronary arteries, arterioles and capillaries during hypertension and left ventricular hypertrophy. Circ. Res. 58, 38-46.
6. Wei, K., Jayaweera, A. R., Firoozan, S., Linka, A., Skyba, D. M., and Kaul, S. (1998). Quantification of myocardial blood flow within ultrasound-induced destruction of icrobubbles administered as a constant venous injection. Circulation 97, 473-483.